Given the diversity of clinical behavior of sarcoma subtypes, survival analysis was also performed for individual sarcoma subtypes with the largest numbers of patients (leiomyosarcoma, UPS, osteosarcoma), and again was not significantly different between the patients with FAP expression in the lower quartile compared to the upper quartile. The gene discussed is FAP; the disease is undifferentiated pleomorphic sarcoma.